Ernexa Therapeutics, Inc. (ERNA)
2.02
-0.03
(-1.46%)
USD |
NASDAQ |
Nov 10, 16:00
2.02
0.00 (0.00%)
After-Hours: 20:00
Ernexa Therapeutics Cash from Operations (Annual) : -7.017M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -7.017M |
| December 31, 2024 | -15.84M |
| December 31, 2023 | -20.41M |
| December 31, 2022 | -20.98M |
| December 31, 2021 | -23.49M |
| December 31, 2020 | -8.101M |
| December 31, 2019 | 2.744M |
| December 31, 2018 | 1.365M |
| December 31, 2017 | 0.549M |
| December 31, 2016 | 0.023M |
| December 31, 2015 | -4.18M |
| December 31, 2014 | -6.385M |
| December 31, 2013 | 1.493M |
| December 31, 2012 | 2.156M |
| December 31, 2011 | 0.574M |
| December 31, 2010 | 2.831M |
| Date | Value |
|---|---|
| December 31, 2009 | 2.503M |
| December 31, 2008 | -2.963M |
| December 31, 2007 | -0.782M |
| December 31, 2006 | 5.835M |
| December 31, 2005 | 3.193M |
| December 31, 2004 | -2.556M |
| December 31, 2003 | 1.098M |
| December 31, 2002 | 1.131M |
| December 31, 2001 | 1.482M |
| December 31, 2000 | 0.404M |
| December 31, 1999 | 0.431M |
| December 31, 1998 | 1.12M |
| December 31, 1997 | -1.004M |
| December 31, 1996 | -8.655M |
| December 31, 1995 | -5.80M |
| December 31, 1994 | -5.391M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Cerenome, Inc. | -20.78M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |
| Savara, Inc. | -101.04M |